Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ProJenX Logo
ProJenX Growth Score
31
CB Rank
28487
Heat Score
50
ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways.
Founded
obfuscation
PrivateGrant New Suffolk, New York, United States1-10 projenx.com
Biopharma
Biotechnology
Health Care
Therapeutics
Overview

ProJenX
Total Funding
obfuscation
Growth Score
31
Heat Score
50

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score31
-1 pts
in past quarter
Heat Score 50
-2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About ProJenX

CB Rank
28487
ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways.
Founded
obfuscation
PrivateGrant New Suffolk, New York, United States1-10 projenx.com
Biopharma
Biotechnology
Health Care
Therapeutics

Funding Rounds

Grant
OBF
in
obfuscation
Series A
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

  • Erin Fleming Logo
    Erin Fleming: Co-Founder & VP Operations
  • Photo of Eric Heil
    Eric Heil: Founding CEO, Board Member & Chairman
    Past Role: Health Quality Partners, Senior Vice President of Global Growth and Opportunity

Details

Legal Name ProJenX, Inc.
Operating Status Active
Company Type For Profit
Founders  Erin Fleming
About the Company
ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways. The company was founded in 2021 and is headquartered in Nissequogue, New York.
Phone Number 917-268-1458
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Insight

See this Growth Insight
ProJenX is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

Prosetin
Prosetin is an oral, brain-penetrant MAP4 kinase inhibitor developed to target motor neuron degeneration in ALS by blocking MAP4K and reducing ER stress.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - ProJenX Logo
Grant - ProJenX
1
obfuscation
The ALS AssociationGrant
obfuscation
Grant - ProJenX Logo
Grant - ProJenX
1
obfuscation
The ALS AssociationGrant
obfuscation
Grant - ProJenX Logo
Grant - ProJenX
1
obfuscation
The ALS AssociationGrant
obfuscation
Grant - ProJenX Logo
Grant - ProJenX
1
obfuscation
The ALS AssociationGrant
obfuscation
Grant - ProJenX Logo
Grant - ProJenX
1
obfuscation
The ALS AssociationGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - ProJenX Logo
Grant - ProJenX
1
obfuscation
The ALS AssociationGrant
obfuscation
Grant - ProJenX Logo
Grant - ProJenX
1
obfuscation
The ALS AssociationGrant
obfuscation
Grant - ProJenX Logo
Grant - ProJenX
1
obfuscation
The ALS AssociationGrant
obfuscation
Grant - ProJenX Logo
Grant - ProJenX
1
obfuscation
The ALS AssociationGrant
obfuscation
Grant - ProJenX Logo
Grant - ProJenX
1
obfuscation
The ALS AssociationGrant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
The ALS Association Logo
The ALS Association
Yes
Grant - ProJenX Logo
Grant - ProJenX
—
The ALS Association Logo
The ALS Association
Yes
Grant - ProJenX Logo
Grant - ProJenX
—
The ALS Association Logo
The ALS Association
Yes
Grant - ProJenX Logo
Grant - ProJenX
—
The ALS Association Logo
The ALS Association
Yes
Grant - ProJenX Logo
Grant - ProJenX
—
The ALS Association Logo
The ALS Association
Yes
Grant - ProJenX Logo
Grant - ProJenX
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Contacts 2

Employee Profiles

News

News and Press

News•Jun 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 16, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 27, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 1, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

270
210.34%
 in past month

IT Spend

$238.9KThis year, ProJenX is projected to spend $238.9K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Industry Week Logo
Industry Week
67
Keynote Speaker Logo
Keynote Speaker
67
Innovation Speaker Logo
Innovation Speaker
67

Active Website Tech Count

32ProJenX is actively using 32 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  SSL by Default.
Sub-Organizations
Frequently Asked Questions

Where is ProJenX's headquarters? ProJenX is located in New Suffolk, New York, United States.Who invested in ProJenX? ProJenX has 2 investors including The ALS Association and  Medical Excellence Capital.When was the last funding round for ProJenX? ProJenX closed its last funding round on
obfuscation
from a Grant round.Who are ProJenX's competitors? Alternatives and possible competitors to ProJenX may include Coya Therapeutics, Amylyx Pharmaceuticals, and  QurAlis.How much funding has ProJenX raised to date? ProJenX has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(d29fb2e 1)
|